Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org comes to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: breast cancer

12/10/2018

A little more context would have boosted already-strong HealthDay story on drug for hot flashes

10/24/2018

Litany of errors hampers Reuters story on experimental breast cancer drug

8/20/2018

Talazoparib touted as ‘promising,’ but is it any better than a similar breast cancer drug that’s already available?

8/16/2018

Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier

6/8/2018

In story on texting program for chemo patients, Reuters Health keeps most study details on the DL

5/22/2018

A study that may help reduce overtreatment of breast cancer gets solid write-up by Bloomberg

5/7/2018

Independent viewpoint helps round out HealthDay story on impact of earlier mammograms

1 3/8/2018

USA Today rehashes PR talking points in story on at-home breast cancer gene test

1/18/2018

‘It’s unknown whether treatment increases survival,’ AP wisely notes about new breast cancer drug

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery